|
1
|
Gosal D, Ross OA and Toft M: Parkinson’s
disease: the genetics of a heterogeneous disorder. Eur J Neurol.
13:616–627. 2006.
|
|
2
|
Pankratz N and Foroud T: Genetics of
Parkinson disease. Genet Med. 9:801–811. 2007. View Article : Google Scholar
|
|
3
|
Di Fonzo A, Wu-Chou YH, Lu CS, et al: A
common missense variant in the LRRK2 gene, Gly2385Arg, associated
with Parkinson’s disease risk in Taiwan. Neurogenetics. 7:133–138.
2006.
|
|
4
|
An XK, Peng R, Li T, et al: LRRK2
Gly2385Arg variant is a risk factor of Parkinson’s disease among
Han Chinese from mainland China. Eur J Neurol. 15:301–305.
2008.
|
|
5
|
Tan EK, Zhao Y, Skipper L, et al: The
LRRK2 Gly2385Arg variant is associated with Parkinson’s disease:
genetic and functional evidence. Hum Genet. 120:857–863. 2007.
|
|
6
|
Ross OA, Soto-Ortolaza AI, Heckman MG, et
al: Genetic Epidemiology Of Parkinson’s Disease (GEO-PD)
Consortium: Association of LRRK2 exonic variants with
susceptibility to Parkinson’s disease: a case-control study. Lancet
Neurol. 10:898–908. 2011.
|
|
7
|
Hughes AJ, Daniel SE, Kilford L and Lees
AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s
disease: a clinico-pathological study of 100 cases. J Neurol
Neurosurg Psychiatry. 55:181–184. 1992.
|
|
8
|
Lesage S, Dürr A and Brice A: LRRK2: a
link between familial and sporadic Parkinson’s disease. Pathol Biol
(Paris). 55:107–110. 2007.
|
|
9
|
Deng H, Le WD, Guo Y, et al: Genetic and
clinical identification of Parkinson’s disease patients with LRRK2
G2019S mutation. Ann Neurol. 57:933–934. 2005.
|
|
10
|
Lesage S, Dürr A, Tazir M, et al; French
Parkinson’s Disease Genetics Study Group. LRRK2 G2019S as a cause
of Parkinson’s disease in North African Arabs. N Engl J Med.
354:422–423. 2006.
|
|
11
|
Ozelius LJ, Senthil G, Saunders-Pullman R,
et al: LRRK2 G2019S as a cause of Parkinson’s disease in Ashkenazi
Jews. N Engl J Med. 354:424–425. 2006.
|
|
12
|
Paisán-Ruíz C, Jain S, Evans EW, et al:
Cloning of the gene containing mutations that cause PARK8-linked
Parkinson’s disease. Neuron. 44:595–600. 2004.PubMed/NCBI
|
|
13
|
Simón-Sánchez J, Martí-Massó JF,
Sánchez-Mut JV, et al: Parkinson’s disease due to the R1441G
mutation in Dardarin: a founder effect in the Basques. Mov Disord.
21:1954–1959. 2006.
|
|
14
|
Patra B, Parsian AJ, Racette BA, et al:
LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of
Parkinson’s disease. Parkinsonism Relat Disord. 15:175–180.
2009.
|
|
15
|
Cookson MR and Bandmann O: Parkinson’s
disease: insights from pathways. Hum Mol Genet. 19:R21–R27.
2010.
|
|
16
|
Mata IF, Kachergus JM, Taylor JP, et al:
Lrrk2 pathogenic substitutions in Parkinson’s disease.
Neurogenetics. 6:171–177. 2005.
|
|
17
|
Tan EK, Zhao Y, Tan L, et al: Analysis of
LRRK2 Gly2385Arg genetic variant in non-Chinese Asians. Mov Disord.
22:1816–1818. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Haubenberger D, Bonelli S, Hotzy C, et al:
A novel LRRK2 mutation in an Austrian cohort of patients with
Parkinson’s disease. Mov Disord. 22:1640–1643. 2007.PubMed/NCBI
|
|
19
|
Toft M, Haugarvoll K, Ross OA, et al:
LRRK2 and Parkinson’s disease in Norway. Acta Neurol Scand Suppl.
187:72–75. 2007.
|
|
20
|
Biskup S, Mueller JC, Sharma M, et al:
Common variants of LRRK2 are not associated with sporadic
Parkinson’s disease. Ann Neurol. 58:905–908. 2005.
|
|
21
|
Paisán-Ruíz C, Lang AE, Kawarai T, et al:
LRRK2 gene in Parkinson disease: mutation analysis and case control
association study. Neurology. 65:696–700. 2005.PubMed/NCBI
|
|
22
|
Li C, Ting Z, Qin X, et al: The prevalence
of LRRK2 Gly2385Arg variant in Chinese Han population with
Parkinson’s disease. Mov Disord. 22:2439–2443. 2007.
|
|
23
|
Farrer MJ, Stone JT, Lin CH, et al: Lrrk2
G2385R is an ancestral risk factor for Pakinson’s disease in Asia.
Parkinsonism Relat Disord. 13:89–92. 2007.PubMed/NCBI
|
|
24
|
Funayama M, Li Y, Tomiyama H, et al:
Leucine-rich repeat kinase 2 G2385R variant is a risk factor for
Parkinson disease in Asian population. Neuroreport. 18:273–275.
2007. View Article : Google Scholar : PubMed/NCBI
|
